Patent · US Active

Method for identifying an agent for treating abnormal kidney function

US10191067B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

Proteomics International Pty Ltd · AU

Inventors

Thomas Stoll · Windorf, DE
Scott Bringans · Kelmscott, AU
Kaye Winfield · Cockatoo, AU
Tammy Casey · Mount Pleasant, AU
Wendy Davis · Fremantle, AU
Kirsten Peters · Baldivis, AU
Timothy Davis · Fremantle, AU
Richard Lipscombe · Perth, AU

Key dates

Filing date	Jun 26, 2017
Grant date	Jan 29, 2019
Priority date	—
Expiry date	Jun 26, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/50
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.